Topiramate and Metformin: Initial Insights into PCOS Weight Management and the Need for Further Research - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring the Role of Topiramate and Metformin in Weight Management for PCOS: Insights and Future Research Directions

  • By

  • Mina Amiri

  • Ricardo Azziz

  • October 29, 2024

Share

  • 1

    A clinical trial showed that topiramate combined with metformin resulted in greater weight loss in women with PCOS compared to metformin alone.

  • 2

    Participants receiving topiramate lost an average of 4.5% of their body weight, while those on metformin and placebo lost only 1.4%.

  • 3

    Paresthesia was the most common side effect of topiramate, reported more frequently in the treatment group than in controls.

  • 4

    Metformin is widely used for managing insulin resistance in PCOS, but the combination with topiramate may enhance weight management.

  • 5

    Further research is needed to explore the long-term safety and efficacy of topiramate in women with PCOS and its impact on various phenotypes.

Original Source(s)

Topiramate and Metformin: Initial Insights into PCOS Weight Management and the Need for Further Research

  • by Mina Amiri, Ricardo Azziz

  • October 29, 2024

Related Content

TOFA may drive weight loss without reducing food intake

The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

Further Reflections on Metabolically Healthy Obesity in Children